Fri 20'th Apr 2018
Calithera Biosciences Stock Analysis
Technical stock analysis for Fri 20'th Apr 2018
Calithera Biosciences fell by -5.43% in the last day from $6.45 to $6.10 The price has risen in 7 of the last 10 days and is up by 11.93% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -57 739 shares and in total 441 674 shares bought and sold for approximately $2.69 million.
|Shorts||4.54% ( 2018-03-29 )|
Calithera Biosciences lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -22.10% during the next 3 months and, with 90% probability hold a price between $3.96 and $6.17 at the end of this period.
There are few to none technical positive signals at the moment. Calithera Biosciences holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $6.20 and $6.81. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday April 19, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 46 and the stock is currently not being overbought or oversold
Support & Resistance
Calithera Biosciences finds support from accumulated volume at $5.85. On the upside the stock meets some resistance just above today's level from accumulated volume at $6.20, $6.95 and $7.10.
The stock is about to test the resistance from accumulated volume at $6.20 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.40 between high and low, or 6.56%. For the last week, the stock has had a daily average volatility of 8.63%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Calithera Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Strong Sell Candidate.
Trade CALA CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder